SAB Biotherapeutics, Inc.
SABS—
SAB Biotherapeutics, Inc.SABS$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-0.79
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$0
Net income
$13.27M
Net margin
—
Gross margin
—
Dividends & financials
SAB Biotherapeutics, Inc. (SABS) reported revenue of $0 and net income of $13.27M, or $-0.79 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.